Skip to main content
Top
Published in: European Journal of Epidemiology 1/2008

01-01-2008 | Diabetes

A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups

Authors: N. R. Bindraban, I. G. M. van Valkengoed, G. Mairuhu, R. W. Koster, F. Holleman, J. B. L. Hoekstra, R. P. Koopmans, K. Stronks

Published in: European Journal of Epidemiology | Issue 1/2008

Login to get access

Abstract

We used a population based study in the Netherlands of 330 Hindustani Surinamese, 586 African Surinamese, and 486 ethnic Dutch (Dutch) to describe the prevalence of the metabolic syndrome (MS) and the association with differences in cardiovascular disease in and between ethnic groups. Fasting blood samples, blood pressure, and anthropometric measurements were obtained. MS was defined according to the criteria of the International Diabetes Federation (IDF) and the criteria of the National Cholesterol Education Program (NCEP). Cardiovascular disease was assessed by the Rose questionnaire and included questions on previous diagnoses of angina pectoris/myocardial infarction, cerebrovascular accident, intermittent claudication. The prevalence of MS (IDF and NCEP) was highest in Hindustani Surinamese men, followed by Dutch and African Surinamese men: 51.0%, 19.4%, and 31.2% (IDF), respectively. Among women, both the Hindustani and African Surinamese participants had a higher prevalence of MS (IDF and NCEP) than the Dutch. The association between the components, MS and cardiovascular disease differed between ethnic groups, in particular among men; OR for MS (NCEP) = 1.0 (0.4–2.7) among Hindustani Surinamese, OR = 4.9 (1.3–18.3) among African Surinamese, and OR = 2.8 (1.1–7.1) among Dutch. However, the differences in MS could not account for the ethnic differences in cardiovascular disease, regardless of the criteria used. The results suggest that, before the criteria can be used to guide practice, they may need to be changed and refined to take into account the differences between ethnic groups as well as the variations by gender.
Literature
1.
go back to reference Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.PubMedCrossRef Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.PubMedCrossRef
2.
go back to reference McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in Hindustani Surinamese. Lancet 1991;337:382–6.PubMedCrossRef McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in Hindustani Surinamese. Lancet 1991;337:382–6.PubMedCrossRef
3.
go back to reference Gerstein HC, Anand SS, Yi QL, et al. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. Diabetes Care 2003;26:144–9.PubMedCrossRef Gerstein HC, Anand SS, Yi QL, et al. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. Diabetes Care 2003;26:144–9.PubMedCrossRef
4.
go back to reference Isomaa B, Almgren P, Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9.PubMedCrossRef Isomaa B, Almgren P, Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9.PubMedCrossRef
5.
go back to reference Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care 2002;25:829–34.PubMedCrossRef Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care 2002;25:829–34.PubMedCrossRef
6.
go back to reference Anand SS, Yi QL, Gerstein HC, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003;29:420–5.CrossRef Anand SS, Yi QL, Gerstein HC, et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003;29:420–5.CrossRef
7.
go back to reference Tillin T, Forouhi N, Johnston DG, et al. Metabolic syndrome and coronary heart disease in South Asians, Afro-Caribbeans and Dutch: a UK population-based cross sectional study. Diabetologia 2005;48:649–6.PubMedCrossRef Tillin T, Forouhi N, Johnston DG, et al. Metabolic syndrome and coronary heart disease in South Asians, Afro-Caribbeans and Dutch: a UK population-based cross sectional study. Diabetologia 2005;48:649–6.PubMedCrossRef
8.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
9.
go back to reference World Health Organization, Department of Non-Communicable Disease Surveillance Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999. World Health Organization, Department of Non-Communicable Disease Surveillance Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
10.
go back to reference Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003;26:1251–7.PubMedCrossRef Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003;26:1251–7.PubMedCrossRef
11.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709–16.PubMedCrossRef Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709–16.PubMedCrossRef
12.
go back to reference Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414–9.PubMedCrossRef Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414–9.PubMedCrossRef
13.
go back to reference Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391–7.PubMedCrossRef Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391–7.PubMedCrossRef
14.
go back to reference Hu G, Qiao Q, Toumilehto J, Balkau B, Borch-Johsnen K, Pyorala K. DECODE Study Group Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 2004;164:1066–76.PubMedCrossRef Hu G, Qiao Q, Toumilehto J, Balkau B, Borch-Johsnen K, Pyorala K. DECODE Study Group Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 2004;164:1066–76.PubMedCrossRef
15.
go back to reference Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. San Antonio Heart Study National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251–7.PubMedCrossRef Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. San Antonio Heart Study National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251–7.PubMedCrossRef
17.
go back to reference Bindraban NR, Stronks K, Klazinga NS. Cardiovascular risk factors for Surinamese in the Netherlands: a literature review. Ned Tijdschr Geneeskd 2003;147:1591–4.PubMed Bindraban NR, Stronks K, Klazinga NS. Cardiovascular risk factors for Surinamese in the Netherlands: a literature review. Ned Tijdschr Geneeskd 2003;147:1591–4.PubMed
18.
go back to reference Agyemang C, Bindraban N, Mairuhu G, van Montfrans G, Koopmans R, Stronks K. Prevalence, awareness, treatment, and control of hypertension among black Surinamese, South Asian Surinamese and white Dutch in Amsterdam, the Netherlands: the SUNSET study. J Hypertens 2005;23:1971–7.PubMedCrossRef Agyemang C, Bindraban N, Mairuhu G, van Montfrans G, Koopmans R, Stronks K. Prevalence, awareness, treatment, and control of hypertension among black Surinamese, South Asian Surinamese and white Dutch in Amsterdam, the Netherlands: the SUNSET study. J Hypertens 2005;23:1971–7.PubMedCrossRef
19.
go back to reference Rose G. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645–58.PubMed Rose G. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645–58.PubMed
20.
go back to reference Fornengo P, Bosio A, Epifani G, Pallisco O, Mancuso A, Pascale C. Prevalence of silent myocardial ischemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors. Diabet Med 2006;23:775–9.PubMedCrossRef Fornengo P, Bosio A, Epifani G, Pallisco O, Mancuso A, Pascale C. Prevalence of silent myocardial ischemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors. Diabet Med 2006;23:775–9.PubMedCrossRef
21.
go back to reference Kharlip J, Naglieri R, Mitchell BD, Ryan KA, Donner TW. Screening for silent coronary heart disease in type 2 diabetes. Diabetes Care 2006;29:692–4.PubMedCrossRef Kharlip J, Naglieri R, Mitchell BD, Ryan KA, Donner TW. Screening for silent coronary heart disease in type 2 diabetes. Diabetes Care 2006;29:692–4.PubMedCrossRef
22.
go back to reference Fischbacher CM, Bhopal R, Unwin N, White M, Alberti KG. The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol 2001;30:1009–16.PubMedCrossRef Fischbacher CM, Bhopal R, Unwin N, White M, Alberti KG. The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol 2001;30:1009–16.PubMedCrossRef
Metadata
Title
A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups
Authors
N. R. Bindraban
I. G. M. van Valkengoed
G. Mairuhu
R. W. Koster
F. Holleman
J. B. L. Hoekstra
R. P. Koopmans
K. Stronks
Publication date
01-01-2008
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 1/2008
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-007-9200-8

Other articles of this Issue 1/2008

European Journal of Epidemiology 1/2008 Go to the issue